feed,title,long_url,short_url
MarketWatch,NRX Pharmaceuticals files Breakthrough Therapy Designation for Zyesami in patients at immediate risk of death from COVID-19,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=NRXP&siteid=rss,https://on.mktw.net/3Exehvf
